Author

Marla L. Watt

Observed names: Marla L Watt, Marla Leigh Watt, Marla Watt

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Eli Lilly (United States), Purdue University West Lafayette, Eli Lilly (Spain)

OpenAlex ID: A5082041869

PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

2010 · Bin Zheng, Zhixiang Liao, et al. · Science Translational Medicine · 857

Pharmacological Characterization of LY593093, an M1 Muscarinic Acetylcholine Receptor-Selective Partial Orthosteric Agonist

2011 · Marla L. Watt, Douglas A. Schober, et al. · Journal of Pharmacology and Experimental Therapeutics · 37

Characterization of PCS1055, a novel muscarinic M4 receptor antagonist

2016 · Carrie H. Croy, Wai Y. Chan, et al. · European Journal of Pharmacology · 26

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy

2021 · Mali Cosden, Sarah Jinn, et al. · Neurobiology of Disease · 22

Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson’s Disease

2023 · Anthony J. Roecker, Kathy M. Schirripa, et al. · ACS Medicinal Chemistry Letters · 17

The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation

2021 · Laura A. Struzyna, Marla L. Watt · Molecular Pharmacology · 17

The Muscarinic Acetylcholine Receptor Agonist BuTAC Mediates Antipsychotic-Like Effects via the M4 Subtype

2013 · Marla L Watt, Linda Rorick-Kehn, et al. · Neuropsychopharmacology · 16

Translational Pharmacology of the Metabotropic Glutamate 2 Receptor–Preferring Agonist LY2812223 in the Animal and Human Brain

2017 · Christian C. Felder, Douglas A. Schober, et al. · Journal of Pharmacology and Experimental Therapeutics · 10

Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists

2015 · Bin Liu, Carrie H. Croy, et al. · Bioorganic & Medicinal Chemistry Letters · 8

Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections

2023 · H. Marie Loughran, Kathy M. Schirripa, et al. · ACS Medicinal Chemistry Letters · 4

Works count: 10

Citation count: 1,014

H-index: 8

I10-index: 8